Recurrent low-grade gliomas: the role of fractionated stereotactic re-irradiation.
OBJECTIVE
To assess the effectiveness of re-irradiation in recurrent low-grade gliomas (LGG).


METHODS
Sixty-three patients were treated with fractionated stereotactic re-irradiation in the case of recurrent gliomas. At primary diagnosis of the tumor, the histology was grade II astrocytoma, oligodendroglioma or oligoastrocytoma. Fifty-two (82.5%) recurrences were in-field, three (4.8%) were localized at the field border, and eight (12.7%) tumors were localized completely out-field of the former RT field, respectively. Using three to four irregular non-coplanar fields formed with a multi-leaf-collimator, we applied a median total dose of 36 Gy (range 15-62 Gy)with a weekly fractionation of 5 x 2 Gy/week depending on the size and the location of the lesion. No concomitant chemotherapy was applied.


RESULTS
Radiation was well tolerated by all patients. No severe side effects occurred. Median overall survival was 111 months (range 12-240 months). Extent of neurosurgical resection significantly influenced overall survival (P = 0.02). Median interval between the first radiation therapy and re-irradiation was 50 months (range 5-204 months). From the time point of re-irradiation, median survival was 23 months. Median progression-free survival from the time point of re-irradiation was 12 months (range 2-63 months). No prognosticators could be identified for survival from re-irradiation and progression free survival.


CONCLUSIONS
Our retrospective data suggest that stereotactically guided fractionated re-irradiation in recurrent glioma represents an effective treatment option with good results and few complications. However, further investigation is warranted to consolidate these results and to combine radiation with chemotherapy in the case of recurrent LGG.
Combs
S E
SE
Department of Radiation Oncology, German Cancer Research Center (DKFZ), INF 280, Germany. s.combs@dkfz.de
Ahmadi
R
R
Schulz-Ertner
D
D
Thilmann
C
C
Debus
J
J
D000328:Adult; D001932:Brain Neoplasms / Q000532:radiotherapy* / Q000601:surgery; D019583:Dose Fractionation, Radiation; D005260:Female; D005910:Glioma / Q000532:radiotherapy* / Q000601:surgery; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000532:radiotherapy*; D011878:Radiotherapy / Q000379:methods*; D011879:Radiotherapy Dosage; D019233:Retreatment; D012189:Retrospective Studies; D013238:Stereotaxic Techniques / Q000295:instrumentation
Int J Radiat Oncol Biol Phys. 2003 Nov 15;57(4):996-1003
14575830
Cancer. 1993 Jul 1;72 (1):190-5
8508405
Eur J Cancer. 1998 Jan;34(1):98-102
9624245
Cancer. 1994 Sep 15;74(6):1784-91
8082081
Semin Radiat Oncol. 2001 Apr;11(2):145-51
11285552
Arch Neurol. 1989 Nov;46(11):1238-9
2818260
Arch Neurol. 1990 Oct;47(10):1138-40
2222248
Cancer. 1985 Mar 1;55(5):919-27
3967199
J Neurol Neurosurg Psychiatry. 1998 May;64(5):581-7
9598670
Br J Cancer. 2003 Jul 21;89(2):232-8
12865907
J Clin Oncol. 2002 May 1;20(9):2267-76
11980997
J Neurosurg. 1989 Jun;70(6):853-61
2715812
Int J Radiat Oncol Biol Phys. 1989 Jun;16(6):1405-9
2542195
Semin Oncol. 1994 Apr;21(2):236-48
8153667
Can J Surg. 1993 Jun;36(3):271-5
8391917
Radiother Oncol. 2000 Nov;57(2):215-23
11054526
J Clin Oncol. 2003 Jul 1;21(13):2525-8
12829671
Int J Radiat Oncol Biol Phys. 1997 Jan 15;37(2):393-8
9069312
J Clin Oncol. 1997 Apr;15(4):1294-301
9193320
Neurology. 2000 Apr 11;54(7):1402-3
10751245
J Clin Oncol. 2003 Feb 15;21(4):646-51
12586801
Radiologe. 1995 Sep;35(9):583-6
8588040
Int J Radiat Oncol Biol Phys. 1994 Jul 1;29(4):719-27
8040017
J Neurosurg. 1984 Oct;61(4):665-73
6470776
J Clin Oncol. 2003 Jun 15;21(12 ):2305-11
12805331
Neurosurgery. 1987 Nov;21(5):615-21
2827052
Int J Radiat Oncol Biol Phys. 1999 Dec 1;45(5):1133-41
10613305
J Neurosurg. 1993 Jun;78(6):909-14
8487073
Cancer. 1997 Jan 15;79(2):370-9
9010111
Oncology. 2000 Feb;58(2):108-16
10705237
Int J Radiat Oncol Biol Phys. 1999 Mar 15;43(5):977-82
10192343
Neurology. 1999 Sep 22;53(5):1141-3
10496285
Ann Oncol. 2003 Apr;14 (4):599-602
12649108
Semin Surg Oncol. 2001 Jan-Feb;20(1):13-23
11291128
Semin Oncol. 2003 Dec;30(6 Suppl 19):10-4
14765378
J Neurol Neurosurg Psychiatry. 1996 Sep;61(3):291-6
8795601
Neurology. 2000 Apr 11;54(7):1442-8
10751254
Clin Neurosurg. 1995;42:488-94
8846613
Int J Radiat Oncol Biol Phys. 2002 Feb 1;52(2):316-24
11872276
J Clin Oncol. 1994 Oct;12(10):2013-21
7931469
Neurosurgery. 1996 May;38(5):872-8; discussion 878-9
8727811
Radiology. 1996 Oct;201(1):275-8
8816559
Cancer. 1994 Apr 1;73(7):1937-45
8137221